These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 29980607)

  • 61. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation.
    El-Salhy M; Winkel R; Casen C; Hausken T; Gilja OH; Hatlebakk JG
    Gastroenterology; 2022 Oct; 163(4):982-994.e14. PubMed ID: 35709830
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation.
    El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14353. PubMed ID: 35302268
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
    Hamazaki M; Sawada T; Yamamura T; Maeda K; Mizutani Y; Ishikawa E; Furune S; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Nakamura M; Fujishiro M
    BMC Gastroenterol; 2022 Jul; 22(1):342. PubMed ID: 35836115
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
    Francavilla R; Piccolo M; Francavilla A; Polimeno L; Semeraro F; Cristofori F; Castellaneta S; Barone M; Indrio F; Gobbetti M; De Angelis M
    J Clin Gastroenterol; 2019 Mar; 53(3):e117-e125. PubMed ID: 29688915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS.
    Benno P; Norin E; Midtvedt T; Hellström PM
    Best Pract Res Clin Gastroenterol; 2019; 40-41():101607. PubMed ID: 31594647
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21
    El-Salhy M; Patcharatrakul T; Gonlachanvit S
    World J Gastroenterol; 2021 Jun; 27(22):2921-2943. PubMed ID: 34168399
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.
    Ahluwalia B; Magnusson MK; Böhn L; Störsrud S; Larsson F; Savolainen O; Ross A; Simrén M; Öhman L
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13860. PubMed ID: 32314514
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial.
    Skjevling L; Goll R; Hanssen HM; Johnsen PH
    BMJ Open; 2024 Jun; 14(6):e073275. PubMed ID: 38858151
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Irritable bowel syndrome and gut microbiota.
    Canakis A; Haroon M; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):28-35. PubMed ID: 31789724
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?
    Shaukat A; Brenner DM
    Am J Gastroenterol; 2019 Jul; 114(7):1032-1033. PubMed ID: 31082878
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
    Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome.
    El-Salhy M; Kristoffersen AB; Valeur J; Casen C; Hatlebakk JG; Gilja OH; Hausken T
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14200. PubMed ID: 34145677
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of Donor-Recipient-Matched Faecal Microbiota Transplantation in Patients with IBS-D: A Single-Centre, Randomized, Double-Blind Placebo-Controlled Study.
    Zhang Y; Wang S; Wang H; Cao M; Wang M; Zhang B; Xiao C; Zhu H; Du S
    Digestion; 2024; 105(6):457-467. PubMed ID: 39084197
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current status of fecal microbiota transplantation for irritable bowel syndrome.
    El-Salhy M; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14157. PubMed ID: 34236740
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
    Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
    Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
    Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
    BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.